Relocate equipment to Intrepid for evidence analysis

The Drug Enforcement Administration (DEA) is seeking to relocate equipment to Intrepid for evidence analysis. The DEA intends to award a firm-fixed price sole source Purchase Order to Agilent Technologies, Inc. for this purpose. The acquisition is being pursued on a sole source basis in accordance with 41 U.S.C. 3304(a)(1). The services covered will include the de-installation, packaging, transportation, re-installation, and qualification of the equipment manufactured by Agilent Technologies. • The equipment to be relocated includes two GC-MS instruments from SFL8 to SFLI. • The intended use is to restore the equipment to full operational status following relocation. • Agilent Technologies is the original manufacturer of the GC-MS instruments and is the only vendor authorized and trained to de-install, package, transport, unpack, reinstall, and properly qualify the instrument in accordance with manufacturer specifications.